Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1

NPR1 介导的植物抗病性的机制见解

基本信息

  • 批准号:
    10390811
  • 负责人:
  • 金额:
    $ 36.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract NPR1 (NONEXPRESSOR OF PATHOGENSIS-RELATED GENES 1) is a master immune regulator in plants. It orchestrates systemic acquired resistance (SAR) by activating PATHOGENESIS-RELATED (PR) genes in response to induction of salicylic acid (SA) during the plant response to pathogenic challenges. Extensive genetic and biochemical studies have shown that NPR1 is a receptor of SA. SA activation of NPR1 triggers genome- wide transcriptional reprograming via NPR1 interactions with a variety of transcription activators and repressors. NPR1 itself is regulated by redox agents, and its proteolytic turnover has profound implications in a wide range of biological functions, including circadian rhythm and resistance to proteotoxic stress in the endoplasmic reticulum. Despite the essential role of NPR1 in plant biology, the molecular details underlying the myriad of NPR1 functions have remained largely unknown. Building upon our initial success in elucidating the structure of apo NPR1 using single-particle cryoEM, here we propose to elucidate the molecular basis of the NPR1 function in plants. Specifically, we will address (1) how SA activates NPR1, (2) how NPR1 interacts with transcription factors and regulators, and (3) how NPR1 is degraded. Information gained from these studies will provide the much-needed mechanistic insights into the SA-NPR1 signaling cascade in plants and help develop disease- resistant crops. As SA is the principle metabolite of aspirin, such knowledge may also contribute to a better understanding of the well-documented medicinal benefits of SA and analogs in humans.
项目总结/摘要 NPR 1(Nonexpressorofpathogenis-relatedgenes 1)是植物的主要免疫调节因子。它 通过激活病原学相关(PR)基因协调全身获得性耐药(SAR), 在植物对病原体挑战的响应期间,对水杨酸(SA)诱导的响应。广泛的遗传 生化研究表明NPR 1是SA的受体。SA激活NPR 1触发基因组- 广泛的转录重编程通过NPR 1与各种转录激活因子和抑制因子的相互作用。 NPR 1本身受氧化还原剂的调节,其蛋白水解周转在广泛的范围内具有深远的意义 生物学功能,包括昼夜节律和抵抗内质网中的蛋白毒性应激 网状细胞。尽管NPR 1在植物生物学中起着重要作用,但其背后的无数分子细节仍然存在。 NPR 1的功能在很大程度上仍然未知。在我们初步成功地阐明了 apo NPR 1使用单粒子cryoEM,在这里,我们建议阐明NPR 1功能的分子基础 在植物中。具体来说,我们将解决(1)SA如何激活NPR 1,(2)NPR 1如何与转录相互作用 因子和调节因子;(3)NPR 1是如何降解的。从这些研究中获得的信息将提供 对植物中SA-NPR 1信号级联的迫切需要的机制见解,并帮助发展疾病- 抗性作物由于SA是阿司匹林的主要代谢产物,因此这些知识也有助于更好地 了解SA和类似物在人类中的良好记录的医学益处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pei Zhou其他文献

Pei Zhou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pei Zhou', 18)}}的其他基金

Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1
NPR1 介导的植物抗病性的机制见解
  • 批准号:
    10793966
  • 财政年份:
    2022
  • 资助金额:
    $ 36.62万
  • 项目类别:
Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1
NPR1 介导的植物抗病性的机制见解
  • 批准号:
    10670797
  • 财政年份:
    2022
  • 资助金额:
    $ 36.62万
  • 项目类别:
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens
广泛有效的 LpxH 抑制剂的发现和验证作为针对多重耐药革兰氏阴性病原体的新疗法
  • 批准号:
    10322657
  • 财政年份:
    2019
  • 资助金额:
    $ 36.62万
  • 项目类别:
Biochemistry and Structure of Lipid A Enzymes
脂质 A 酶的生物化学和结构
  • 批准号:
    9230402
  • 财政年份:
    2016
  • 资助金额:
    $ 36.62万
  • 项目类别:
Structural and Biochemical Studies of LpxC Inhibition
LpxC 抑制的结构和生化研究
  • 批准号:
    7846499
  • 财政年份:
    2009
  • 资助金额:
    $ 36.62万
  • 项目类别:
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins
RNAPII CTD 相互作用蛋白的结构、生化和功能研究
  • 批准号:
    7904244
  • 财政年份:
    2008
  • 资助金额:
    $ 36.62万
  • 项目类别:
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins
RNAPII CTD 相互作用蛋白的结构、生化和功能研究
  • 批准号:
    7526527
  • 财政年份:
    2008
  • 资助金额:
    $ 36.62万
  • 项目类别:
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins
RNAPII CTD 相互作用蛋白的结构、生化和功能研究
  • 批准号:
    7679450
  • 财政年份:
    2008
  • 资助金额:
    $ 36.62万
  • 项目类别:
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins
RNAPII CTD 相互作用蛋白的结构、生化和功能研究
  • 批准号:
    8118895
  • 财政年份:
    2008
  • 资助金额:
    $ 36.62万
  • 项目类别:
Structure and Mechanism of LpxC in Lipid A Biosynthesis
LpxC在脂质A生物合成中的结构和机制
  • 批准号:
    6986164
  • 财政年份:
    2003
  • 资助金额:
    $ 36.62万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了